| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |